# Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

> **NCT02584244** · PHASE1,PHASE2 · RECRUITING · sponsor: **Lumicell, Inc.** · enrollment: 66 (estimated)

## Conditions studied

- Colorectal Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Gastric Cancer

## Interventions

- **DRUG:** LUM015
- **DEVICE:** LUM 2.6 Imaging Device

## Key facts

- **NCT ID:** NCT02584244
- **Lead sponsor:** Lumicell, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-08-04
- **Primary completion:** 2026-12
- **Final completion:** 2027-04
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584244, "Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02584244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*